Compositions comprising fetal liver cells and methods useful for HCV infection

Details for Australian Patent Application No. 2004295702 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Byrn, Randal

Agent Wrays

Pub. Number AU-A-2004295702

PCT Pub. Number WO2005/054450

Priority 60/526,411 01.12.03 US

Filing date 1 December 2004

Wipo publication date 16 June 2005

International Classifications

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

A01N 1/02 (2006.01) Preservation of bodies of humans or animals, or plants, or parts thereof - Preservation of living parts

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054450 Priority application(s): WO2005/054450

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295705-A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan

2004295699-Methods and compositions for immunohistochemical detection